Detalhe da pesquisa
1.
Multifaceted strategy based on automated text messaging after a recent heart failure admission: the MESSAGE-HF Randomized Clinical Trial
JAMA cardiol. (Online);
9(2): 105-113, 2024.
Artigo
em Inglês
| CONASS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1531070
2.
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
EuroIntervention;
19(4): E323-E329, jul.2023.
Artigo
em Inglês
| CONASS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1444455
3.
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: rationale and design of the RIVER trial
Am. heart j;
(231): 128-136, Jan. 2021. tab.
Artigo
em Inglês
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1145450
4.
Tópicos Emergentes em Insuficiência Cardíaca: O Futuro na Insuficiência Cardíaca: Telemonitoramento, Wearables, Inteligência Artificial e Ensino na Era Pós-Pandemia / Emerging Topics in Heart Failure: The Future of Heart Failure: Telemonitoring, Wearables, Artificial Intelligence and Learning in the Post-Pandemic Era
Arq. bras. cardiol;
115(6): 1190-1192, dez. 2020.
Artigo
em Inglês, Português
| LILACS | ID: biblio-1152952
5.
Rivaroxaban in patients with atrial fibrillation and a bioprosthetic mitral valve
N. Engl. j. med;
383(22): 1-11, Nov. 2020. graf, tab
Artigo
em Inglês
| CONASS, SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1146447